Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

BUY
$24.58 - $42.82 $26,669 - $46,459
1,085 Added 79.02%
2,458 $69,000
Q3 2020

Nov 13, 2020

BUY
$32.95 - $50.25 $45,240 - $68,993
1,373 New
1,373 $68,000

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.